Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Belka

Showing results (1-10 of 599) with videos related to

Pageof 60
Sort By:
Current Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Death receptor ligands: new strategies for combined treatment with ionizing radiationPatrizia Marini, Claus Belka
Radiation Oncology (London, England)|January 30, 2008
Severe skin reaction secondary to concomitant radiotherapy plus cetuximabBernhard Berger, Claus Belka
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
Evidence-based radiation oncology: oesophagusBernhard Berger, Claus Belka
Results and Problems in Cell Differentiation|July 8, 2009
Targeting death-receptors in radiation therapyOlivier Niemöller, Claus Belka
Radiation Oncology (London, England)|October 19, 2006
Isobologram analysis of triple therapiesMaximilian Niyazi, Claus Belka
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Palliative percutaneous radiotherapy in non-small-cell lung cancerWilfried Budach, Claus Belka
International Journal of Radiation Biology|September 24, 2016
In the linear quadratic model, the Poisson approximation and the Zaider-Minerbo formula agree on the ranking of tumor control probabilities, up to a critical cell birth rateHendrik Ballhausen, Claus Belka
Physics in Medicine and Biology|December 17, 2005
A normal tissue dose response model of dynamic repair processesMarkus Alber, Claus Belka
Cancer Letters|August 10, 2011
Radiotherapy and TRAIL for cancer therapyOlivier M Niemoeller, Claus Belka
Radiation Oncology (London, England)|May 26, 2006
Why "radiation oncology"Claus Belka, Kevin A Camphausen
Pageof 60

Showing results (1-10 of 599) with videos related to

Sort By:
Pageof 60
Current Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Death receptor ligands: new strategies for combined treatment with ionizing radiationPatrizia Marini, Claus Belka
Radiation Oncology (London, England)|January 30, 2008
Severe skin reaction secondary to concomitant radiotherapy plus cetuximabBernhard Berger, Claus Belka
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
Evidence-based radiation oncology: oesophagusBernhard Berger, Claus Belka
Results and Problems in Cell Differentiation|July 8, 2009
Targeting death-receptors in radiation therapyOlivier Niemöller, Claus Belka
Radiation Oncology (London, England)|October 19, 2006
Isobologram analysis of triple therapiesMaximilian Niyazi, Claus Belka
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Palliative percutaneous radiotherapy in non-small-cell lung cancerWilfried Budach, Claus Belka
International Journal of Radiation Biology|September 24, 2016
In the linear quadratic model, the Poisson approximation and the Zaider-Minerbo formula agree on the ranking of tumor control probabilities, up to a critical cell birth rateHendrik Ballhausen, Claus Belka
Physics in Medicine and Biology|December 17, 2005
A normal tissue dose response model of dynamic repair processesMarkus Alber, Claus Belka
Cancer Letters|August 10, 2011
Radiotherapy and TRAIL for cancer therapyOlivier M Niemoeller, Claus Belka
Radiation Oncology (London, England)|May 26, 2006
Why "radiation oncology"Claus Belka, Kevin A Camphausen
Pageof 60